Intuitive Surgical, Inc. Selling, General and Administrative Expense
Intuitive Surgical, Inc. (ISRG) reported Selling, General and Administrative Expense of $617.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-21
- Intuitive Surgical, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $617.90M, a 10.10% increase year-over-year.
- Intuitive Surgical, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $613.30M, a 8.86% increase year-over-year.
- Intuitive Surgical, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $687.10M, a 12.16% increase year-over-year.
- Intuitive Surgical, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $573.30M, a 12.28% increase year-over-year.
- Intuitive Surgical, Inc. selling, general and administrative expense for fiscal 2025 was $2.38B, a 11.45% increase from fiscal 2024.
- Intuitive Surgical, Inc. selling, general and administrative expense for fiscal 2024 was $2.14B, a 8.97% increase from fiscal 2023.
- Intuitive Surgical, Inc. selling, general and administrative expense for fiscal 2023 was $1.96B, a 12.87% increase from fiscal 2022.
- Intuitive Surgical, Inc. selling, general and administrative expense for fiscal 2022 was $1.74B, a 18.64% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $617.90M 10-Q · filed 2026-07-21 | $1.23B 10-Q · filed 2026-07-21 | $1.92B derived: sum of 3 quarters · filed 2026-07-21 | $2.49B derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2026-03-31 | $613.30M 10-Q · filed 2026-04-22 | $1.30B derived: sum of 2 quarters · filed 2026-04-22 | $1.87B derived: sum of 3 quarters · filed 2026-04-22 | $2.43B derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-12-31 | $687.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.26B derived: sum of 2 quarters · filed 2026-02-03 | $1.82B derived: sum of 3 quarters · filed 2026-07-21 | $2.38B 10-K · filed 2026-02-03 | ||||
| 2025-09-30 | $573.30M 10-Q · filed 2025-10-22 | $1.13B derived: sum of 2 quarters · filed 2026-07-21 | $1.70B 10-Q · filed 2025-10-22 | $2.31B derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-06-30 | $561.20M 10-Q · filed 2026-07-21 | $1.12B 10-Q · filed 2026-07-21 | $1.74B derived: sum of 3 quarters · filed 2026-07-21 | $2.25B derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-03-31 | $563.40M 10-Q · filed 2026-04-22 | $1.18B derived: sum of 2 quarters · filed 2026-04-22 | $1.69B derived: sum of 3 quarters · filed 2026-04-22 | $2.21B derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-31 | $612.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.12B derived: sum of 2 quarters · filed 2026-02-03 | $1.65B derived: sum of 3 quarters · filed 2026-02-03 | $2.14B 10-K · filed 2026-02-03 | ||||
| 2024-09-30 | $510.60M 10-Q · filed 2025-10-22 | $1.04B derived: sum of 2 quarters · filed 2025-10-22 | $1.53B 10-Q · filed 2025-10-22 | $2.09B derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-06-30 | $525.30M 10-Q · filed 2025-07-23 | $1.02B 10-Q · filed 2025-07-23 | $1.58B derived: sum of 3 quarters · filed 2026-02-03 | $2.04B derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-03-31 | $491.50M 10-Q · filed 2025-04-23 | $1.06B derived: sum of 2 quarters · filed 2026-02-03 | $1.51B derived: sum of 3 quarters · filed 2026-02-03 | $1.97B derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2023-12-31 | $567.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.02B derived: sum of 2 quarters · filed 2026-02-03 | $1.48B derived: sum of 3 quarters · filed 2026-02-03 | $1.96B 10-K · filed 2026-02-03 | ||||
| 2023-09-30 | $452.00M 10-Q · filed 2024-10-18 | $916.30M derived: sum of 2 quarters · filed 2024-10-18 | $1.40B 10-Q · filed 2024-10-18 | $1.89B derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2023-06-30 | $464.30M 10-Q · filed 2024-07-19 | $944.80M 10-Q · filed 2024-07-19 | $1.44B derived: sum of 3 quarters · filed 2025-01-31 | $1.88B derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2023-03-31 | $480.50M 10-Q · filed 2024-04-19 | $974.80M derived: sum of 2 quarters · filed 2025-01-31 | $1.41B derived: sum of 3 quarters · filed 2025-01-31 | $1.83B derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2022-12-31 | $494.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $930.40M derived: sum of 2 quarters · filed 2025-01-31 | $1.35B derived: sum of 3 quarters · filed 2025-01-31 | $1.74B 10-K · filed 2025-01-31 | ||||
| 2022-09-30 | $436.10M 10-Q · filed 2023-10-20 | $854.50M derived: sum of 2 quarters · filed 2023-10-20 | $1.25B 10-Q · filed 2023-10-20 | $1.67B derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2022-06-30 | $418.40M 10-Q · filed 2023-07-24 | $809.50M 10-Q · filed 2023-07-24 | $1.24B derived: sum of 3 quarters · filed 2024-01-31 | $1.60B derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2022-03-31 | $391.10M 10-Q · filed 2023-04-20 | $818.10M derived: sum of 2 quarters · filed 2024-01-31 | $1.18B derived: sum of 3 quarters · filed 2024-01-31 | $1.53B derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2021-12-31 | $427.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $790.30M derived: sum of 2 quarters · filed 2024-01-31 | $1.14B derived: sum of 3 quarters · filed 2024-01-31 | $1.47B 10-K · filed 2024-01-31 | ||||
| 2021-09-30 | $363.30M 10-Q · filed 2022-10-21 | $713.50M derived: sum of 2 quarters · filed 2022-10-21 | $1.04B 10-Q · filed 2022-10-21 | $1.37B derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-06-30 | $350.20M 10-Q · filed 2022-07-22 | $676.20M 10-Q · filed 2022-07-22 | $1.01B derived: sum of 3 quarters · filed 2023-02-10 | $1.31B derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-03-31 | $326.00M 10-Q · filed 2022-04-22 | $656.20M derived: sum of 2 quarters · filed 2023-02-10 | $955.10M derived: sum of 3 quarters · filed 2023-02-10 | $1.23B derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2020-12-31 | $330.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $629.10M derived: sum of 2 quarters · filed 2023-02-10 | $908.20M derived: sum of 3 quarters · filed 2023-02-10 | $1.22B 10-K · filed 2023-02-10 | ||||
| 2020-09-30 | $298.90M 10-Q · filed 2021-10-20 | $578.00M derived: sum of 2 quarters · filed 2021-10-20 | $886.10M 10-Q · filed 2021-10-20 | $1.23B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $279.10M 10-Q · filed 2021-07-21 | $587.20M 10-Q · filed 2021-07-21 | $929.00M derived: sum of 3 quarters · filed 2022-02-03 | $1.21B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $308.10M 10-Q · filed 2021-04-21 | $649.90M derived: sum of 2 quarters · filed 2022-02-03 | $933.90M derived: sum of 3 quarters · filed 2022-02-03 | $1.21B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $341.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $625.80M derived: sum of 2 quarters · filed 2022-02-03 | $905.00M derived: sum of 3 quarters · filed 2022-02-03 | $1.18B 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $284.00M 10-Q · filed 2020-10-19 | $563.20M derived: sum of 2 quarters · filed 2020-10-19 | $836.60M 10-Q · filed 2020-10-19 | $1.12B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-06-30 | $279.20M 10-Q · filed 2020-07-23 | $552.60M 10-Q · filed 2020-07-23 | $836.40M derived: sum of 3 quarters · filed 2021-02-10 | $1.06B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-03-31 | $273.40M 10-Q · filed 2020-04-17 | $557.20M derived: sum of 2 quarters · filed 2021-02-10 | $778.60M derived: sum of 3 quarters · filed 2021-02-10 | $1.04B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2018-12-31 | $283.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $505.20M derived: sum of 2 quarters · filed 2021-02-10 | $765.00M derived: sum of 3 quarters · filed 2021-02-10 | $986.60M 10-K · filed 2021-02-10 | ||||
| 2018-09-30 | $221.40M 10-Q · filed 2019-10-18 | $481.20M derived: sum of 2 quarters · filed 2019-10-18 | $702.80M 10-Q · filed 2019-10-18 | $920.70M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-06-30 | $259.80M 10-Q · filed 2019-07-22 | $481.40M 10-Q · filed 2019-07-22 | $699.30M derived: sum of 3 quarters · filed 2020-02-07 | $903.40M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-03-31 | $221.60M 10-Q · filed 2019-04-19 | $439.50M derived: sum of 2 quarters · filed 2020-02-07 | $643.60M derived: sum of 3 quarters · filed 2020-02-07 | $829.20M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2017-12-31 | $217.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $422.00M derived: sum of 2 quarters · filed 2020-02-07 | $607.60M derived: sum of 3 quarters · filed 2020-02-07 | $810.50M 10-K · filed 2020-02-07 | $810.90M 10-K · filed 2018-02-02 | |||
| 2017-09-30 | $204.10M 10-Q · filed 2018-10-22 | $204.80M 10-Q · filed 2017-10-20 | $389.70M derived: sum of 2 quarters · filed 2018-10-22 | $592.60M 10-Q · filed 2018-10-22 | $591.70M 10-Q · filed 2017-10-20 | $784.60M derived: sum of 4 quarters · filed 2019-02-04 | ||
| 2017-06-30 | $185.60M 10-Q · filed 2018-07-20 | $185.80M 10-Q · filed 2017-07-21 | $388.50M 10-Q · filed 2018-07-20 | $386.90M 10-Q · filed 2017-07-21 | $580.50M derived: sum of 3 quarters · filed 2019-02-04 | $748.50M derived: sum of 4 quarters · filed 2019-02-04 | ||
| 2017-03-31 | $202.90M 10-Q · filed 2018-04-18 | $201.10M 10-Q · filed 2017-04-19 | $394.90M derived: sum of 2 quarters · filed 2019-02-04 | $562.90M derived: sum of 3 quarters · filed 2019-02-04 | $733.70M derived: sum of 4 quarters · filed 2019-02-04 | |||
| 2016-12-31 | $192.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $360.00M derived: sum of 2 quarters · filed 2019-02-04 | $530.80M derived: sum of 3 quarters · filed 2019-02-04 | $703.60M 10-K · filed 2019-02-04 | $705.30M 10-K · filed 2017-02-06 | |||
| 2016-09-30 | $168.00M 10-Q · filed 2017-10-20 | $338.80M derived: sum of 2 quarters · filed 2017-10-20 | $511.60M 10-Q · filed 2017-10-20 | $671.90M derived: sum of 4 quarters · filed 2018-02-02 | ||||
| 2016-06-30 | $170.80M 10-Q · filed 2017-07-21 | $343.60M 10-Q · filed 2017-07-21 | $503.90M derived: sum of 3 quarters · filed 2018-02-02 | $658.80M derived: sum of 4 quarters · filed 2018-02-02 | ||||
| 2016-03-31 | $172.80M 10-Q · filed 2017-04-19 | $333.10M derived: sum of 2 quarters · filed 2018-02-02 | $488.00M derived: sum of 3 quarters · filed 2018-02-02 | $651.30M derived: sum of 4 quarters · filed 2018-02-02 | ||||
| 2015-12-31 | $160.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $315.20M derived: sum of 2 quarters · filed 2018-02-02 | $478.50M derived: sum of 3 quarters · filed 2018-02-02 | $640.50M 10-K · filed 2018-02-02 | ||||
| 2015-09-30 | $154.90M 10-Q · filed 2016-10-19 | $318.20M derived: sum of 2 quarters · filed 2016-10-19 | $480.20M 10-Q · filed 2016-10-19 | $640.20M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2015-06-30 | $163.30M 10-Q · filed 2016-07-20 | $325.30M 10-Q · filed 2016-07-20 | $485.30M derived: sum of 3 quarters · filed 2017-02-06 | $639.30M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2015-03-31 | $162.00M 10-Q · filed 2016-04-19 | $322.00M derived: sum of 2 quarters · filed 2017-02-06 | $476.00M derived: sum of 3 quarters · filed 2017-02-06 | $637.20M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2014-12-31 | $160.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06 | $314.00M derived: sum of 2 quarters · filed 2017-02-06 | $475.20M derived: sum of 3 quarters · filed 2017-02-06 | $691.00M 10-K · filed 2017-02-06 | ||||
| 2014-09-30 | $154.00M 10-Q · filed 2015-10-21 | $315.20M derived: sum of 2 quarters · filed 2015-10-21 | $531.00M 10-Q · filed 2015-10-21 | $678.70M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2014-06-30 | $161.20M 10-Q · filed 2015-07-22 | $377.00M 10-Q · filed 2015-07-22 | $524.70M derived: sum of 3 quarters · filed 2016-02-02 | $664.00M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2014-03-31 | $215.80M 10-Q · filed 2015-04-22 | $363.50M derived: sum of 2 quarters · filed 2016-02-02 | $502.80M derived: sum of 3 quarters · filed 2016-02-02 | $648.30M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2013-12-31 | $147.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $287.00M derived: sum of 2 quarters · filed 2016-02-02 | $432.50M derived: sum of 3 quarters · filed 2016-02-02 | $574.00M 10-K · filed 2016-02-02 | ||||
| 2013-09-30 | $139.30M 10-Q · filed 2014-10-23 | $284.80M derived: sum of 2 quarters · filed 2014-10-23 | $426.30M 10-Q · filed 2014-10-23 | $574.40M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2013-06-30 | $145.50M 10-Q · filed 2014-07-24 | $287.00M 10-Q · filed 2014-07-24 | $435.10M derived: sum of 3 quarters · filed 2015-02-06 | $564.10M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2013-03-31 | $141.50M 10-Q · filed 2014-04-25 | $289.60M derived: sum of 2 quarters · filed 2015-02-06 | $418.60M derived: sum of 3 quarters · filed 2015-02-06 | $539.50M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2012-12-31 | $148.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $277.10M derived: sum of 2 quarters · filed 2015-02-06 | $398.00M derived: sum of 3 quarters · filed 2015-02-06 | $522.20M 10-K · filed 2015-02-06 | ||||
| 2012-09-30 | $129.00M 10-Q · filed 2013-10-18 | $249.90M derived: sum of 2 quarters · filed 2013-10-18 | $374.10M 10-Q · filed 2013-10-18 | $496.10M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-06-30 | $120.90M 10-Q · filed 2013-07-22 | $245.10M 10-Q · filed 2013-07-22 | $367.10M derived: sum of 3 quarters · filed 2014-02-03 | $478.30M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-03-31 | $124.20M 10-Q · filed 2013-04-19 | $246.20M derived: sum of 2 quarters · filed 2014-02-03 | $357.40M derived: sum of 3 quarters · filed 2014-02-03 | $463.90M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2011-12-31 | $122.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | $233.20M derived: sum of 2 quarters · filed 2014-02-03 | $339.70M derived: sum of 3 quarters · filed 2014-02-03 | $438.80M 10-K · filed 2014-02-03 | ||||
| 2011-09-30 | $111.20M 10-Q · filed 2012-10-18 | $217.70M derived: sum of 2 quarters · filed 2012-10-18 | $316.80M 10-Q · filed 2012-10-18 | $412.60M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-06-30 | $106.50M 10-Q · filed 2012-07-23 | $205.60M 10-Q · filed 2012-07-23 | $301.40M derived: sum of 3 quarters · filed 2013-02-04 | $393.00M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-03-31 | $99.10M 10-Q · filed 2012-04-19 | $194.90M derived: sum of 2 quarters · filed 2013-02-04 | $286.50M derived: sum of 3 quarters · filed 2013-02-04 | $375.10M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2010-12-31 | $95.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04 | $187.40M derived: sum of 2 quarters · filed 2013-02-04 | $276.00M derived: sum of 3 quarters · filed 2013-02-04 | $358.80M 10-K · filed 2013-02-04 | ||||
| 2010-09-30 | $91.60M 10-Q · filed 2011-10-19 | $180.20M derived: sum of 2 quarters · filed 2011-10-19 | $263.00M 10-Q · filed 2011-10-19 | $342.00M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2010-06-30 | $88.60M 10-Q · filed 2011-07-20 | $171.40M 10-Q · filed 2011-07-20 | $250.40M derived: sum of 3 quarters · filed 2012-02-06 | $320.30M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2010-03-31 | $82.80M 10-Q · filed 2011-04-20 | $161.80M derived: sum of 2 quarters · filed 2012-02-06 | $231.70M derived: sum of 3 quarters · filed 2012-02-06 | $299.00M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2009-12-31 | $79.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $148.90M derived: sum of 2 quarters · filed 2012-02-06 | $216.20M derived: sum of 3 quarters · filed 2012-02-06 | $278.60M 10-K · filed 2012-02-06 | $278.51M 10-K · filed 2010-01-29 | |||
| 2009-09-30 | $69.90M 10-Q · filed 2010-10-20 | $69.86M 10-Q · filed 2009-10-21 | $137.20M derived: sum of 2 quarters · filed 2010-10-20 | $199.60M 10-Q · filed 2010-10-20 | $199.50M 10-Q · filed 2009-10-21 | $261.37M derived: sum of 4 quarters · filed 2011-02-01 | ||
| 2009-06-30 | $67.30M 10-Q · filed 2010-07-23 | $67.28M 10-Q · filed 2009-07-23 | $129.70M 10-Q · filed 2010-07-23 | $129.64M 10-Q · filed 2009-07-23 | $191.47M derived: sum of 3 quarters · filed 2011-02-01 | $254.16M derived: sum of 4 quarters · filed 2011-02-01 | ||
| 2009-03-31 | $62.40M 10-Q · filed 2010-04-20 | $124.17M derived: sum of 2 quarters · filed 2011-02-01 | $186.86M derived: sum of 3 quarters · filed 2011-02-01 | $244.37M derived: sum of 4 quarters · filed 2011-02-01 | ||||
| 2008-12-31 | $61.77M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01 | $124.46M derived: sum of 2 quarters · filed 2011-02-01 | $181.97M derived: sum of 3 quarters · filed 2011-02-01 | $230.60M 10-K · filed 2011-02-01 | $230.57M 10-K · filed 2010-01-29 | |||
| 2008-09-30 | $62.69M 10-Q · filed 2009-10-21 | $120.20M derived: sum of 2 quarters · filed 2009-10-21 | $168.83M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $57.50M 10-Q · filed 2009-07-23 | $106.14M 10-Q · filed 2009-07-23 | ||||||
| 2007-12-31 | $158.69M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |